Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV NAC for Renal Protection in Cardiac Surgery
NCT00187330Phase 2Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Mar 2004
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in chronic kidney disease (CKD) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoint: Change in peak serum creatinine from baseline. Started Mar 2004; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT00187330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00187330.